Skip to main content

MS news

Our news web pages include ground-breaking multiple sclerosis news and research from around the world. 

These news stories are taken from external sources and as such, MS-UK does not verify, endorse or accept responsibility for their content.

Some of these pages have been written for medical professionals and this can be reflected in the complexity of language and content.

Supporting you

We’re here to support you, whether you are awaiting a diagnosis of multiple sclerosis or have been living with the condition for years. 

Find out more about the MS-UK Helpline

Find out more about our Choices booklets

Find out more about New Pathways magazine

 


A large study of multiple sclerosis patients has concluded clinical and brain imaging assessments drawn from magnetic resonance imaging (MRI) scans are poor measures of long-term prognosis for...
New research from the University of Dundee, and funded by Arthritis Research UK and the MRC, has shown that targeting a specific group of enzymes could be a viable strategy for treating autoimmune...
A new study, published in Neurology, has pointed to a possible benefit to patients of commencing MS treatment as soon as possible after symptoms appear. In 2005, researchers recruited 468 patients...
Patients with aggressive onset multiple sclerosis (AOMS), characterised by a rapidly progressing disease course and accumulation of disability, may benefit from early aggressive therapies instead of...
Transcutaneous electrical nerve stimulation (TENS) might be an option to treat spasticity, one of the more common symptoms of multiple sclerosis, according to a review conducted by researchers from...
A protein activated by vitamin D could be involved in repairing damage to myelin in people with multiple sclerosis (MS), according to new research from the University of Cambridge. The study,...
Women with multiple sclerosis and people diagnosed with the condition at a younger age are more likely to have a benign course of MS, remaining fully functional for decades, according to researchers...
Researchers have developed an antibody with potential therapeutic effects that could help in the treatment of multiple sclerosis. Inserm Unit U919, directed by Prof. Denis Vivien ("Serine Proteases...
Merck, a leading science and technology company, today announced that the European Medicines Agency (EMA) has accepted for review the Marketing Authorization Application (MAA) of the investigational...
A study published by researchers from Bristol University claims to show the immune system can be taught to stop treating harmless everyday proteins as if they were dangerous invasive diseases. By...

Pages